Interferon-Beta 1a and SARS Coronavirus Replication
CHILDREN'S HOSPITAL CINCINNATI OH
Pagination or Media Count:
A global outbreak of severe acute respiratory syndrome SARS caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon-beta 1a potently inhibits SARS coronavirus replication in vitro.
- Anatomy and Physiology
- Medicine and Medical Research